Company: LHI
Filing Date: 2025-11-20
Form Type: F-1/A
Source: 0001213900-25-112807
Chunk: 230

Company: Living Homeopathy International Ltd.
Filing Date: 2025-11-20
Form: F-1/A
Chunk 230
---
as to the laws of PRC will be passed upon for us by Han Kun Law Offices.

Certain legal matters with respect to U.S. federal and New York State law in connection with this offering will be passed upon for the underwriters by Loeb & Loeb LLP.

<div align='center'>EXPERTS</div>

The consolidated financial
statements for the years ended March 31, 2025 and 2024 included in this prospectus have been so included in reliance on the report of
WWC, P.C., an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.
The office of WWC, P.C. is located at 2010 Pioneer Ct, San Mateo, CA 94403

<div align='center'>INTERESTS OF NAMED EXPERTS AND COUNSEL</div>

No expert or counsel named in this prospectus as having prepared or certified any part of this prospectus or having given an opinion upon the validity of the securities being registered or upon other legal matters in connection with the registration or offering of the Class A Ordinary Shares was employed on a contingency basis, or had, or is to receive, in connection with the offering, a substantial interest, direct or indirect, in the registrant. Nor was any such person connected with the registrant as a promoter, managing or principal Underwriter, voting trustee, director, officer, or employee.

<div align='center'>DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION</div>

Insofar as indemnification for liabilities arising under the Securities Act, may be permitted to Living Homeopathy’s directors, officers or persons controlling Living Homeopathy, Living Homeopathy has been advised that it is the SEC’s opinion that such indemnification is against public policy as expressed in such act and is, therefore, unenforceable.

<div align='center'>WHERE YOU CAN FIND ADDITIONAL INFORMATION</div>

We have filed a registration statement on Form F-1,
including exhibits with the SEC, under the Securities Act with respect to the Class A Ordinary Shares to be sold in this offering. This
prospectus, which constitutes a part of the registration statement on Form F-1, does not contain all of the information contained
in the registration statement. You should read our registration statements and their exhibits and schedules for further information with
respect to us and the Class A Ordinary Shares.

Immediately upon the completion of this offering, we will be subject to periodic reporting and other informational requirements of